nanomaterials also help to enhance the solubility of non‐soluble drug molecules, increase their bioavailability, and reduce the side effects caused by synthetic drugs.
Although nanotechnology in general, and nanomaterials in particular, have great potential in various avenues related to biomedicine, in some cases the cost factor becomes a hindrance in its use. Moreover, certain nanoscale materials lack long‐term safety data, therefore such issues need to be addressed. Apart from these challenges, nanomaterials and their approval methods have not been well defined until now, which brings another limitation and takes even more time in developing clinically useful nanotechnology‐based drug delivery systems and therapies.
References
1 Abbasi, E., Aval, S.F., Akbarzadeh, A. et al. (2014). Dendrimers: synthesis, applications, and properties. Nanoscale Research Letters 9 (1): 247. https://doi.org/10.1186/1556‐276x‐9‐247.
2 Abdallah, M.H. (2013). Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin. International Journal of Pharmacy and Pharmaceutical Sciences 5 (4): 560–567.
3 Abiodun‐Solanke, I.M.F., Ajayi, D.M., and Arigbede, A.O. (2014). Nanotechnology and its application in dentistry. Annals of Medical and Health Science Research 4 (3): S171–S177.
4 Adeyemi, O.S. and Sulaiman, F.A. (2015). Evaluation of metal nanoparticles for drug delivery systems. Journal of Biomedical Research 29 (2): 145–149.
5 Ahmed, M. and Douek, M. (2013). The role of magnetic nanoparticles in the localization and treatment of breast cancer. BioMed Research International 2013 (281230): 1–13.
6 An, X., Zhang, F., Zhu, Y., and Shen, W. (2010). Photo‐induced drug release from thermosensitive AuNPs‐liposome using a AuNPs‐switch. Chemical Communications 46: 7202–7204.
7 Anderson, S.D., Gwenin, V.V., and Gwenin, C.D. (2019). Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications. Nanoscale Research Letters 14: 188. https://doi.org/10.1186/s11671‐019‐3019‐6.
8 Auría‐Soro, C., Nesma, T., Juanes‐Velasco, P. et al. (2019). Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine. Nanomaterials 9 (10): 1365. https://doi.org/10.3390/nano9101365.
9 Badar, A., Pachera, S., Ansari, A.S., and Lohiya, N.K. (2019). Nano based drug delivery systems: present and future prospects. Nanomedicine and Nanotechnology Journal 2 (1): 121.
10 Bangham, A.D. and Horne, R.W. (1964). Negative staining of phospholipids and their structural modification by surface‐active agents as observed in the electron microscope. Journal of Molecular Biology 8 (5): 660–668.
11 Baptista, P.V. (2014). Nanodiagnostics: leaving the research lab to enter the clinics? Diagnosis (Berl) 1: 305–309.
12 Bartelds, R., Nematollahi, M.H., Pols, T. et al. (2018). Niosomes, an alternative for liposomal delivery. PLoS One 13 (4): e0194179. https://doi.org/10.1371/journal.pone.0194179.
13 Beishon, M. (2013). Exploiting a nano‐sized breach in cancer's defenses. Cancer World: 14–21.
14 Bejarano, J., Navarro‐Marquez, M., Morales‐Zavala, F. et al. (2018). Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches. Theranostics 8 (17): 4710–4732.
15 Beyth, N., Houri‐Haddad, Y., Domb, A. et al. (2015). Alternative antimicrobial approach: nano‐antimicrobial materials. Evidence‐based Complementary and Alternative Medicine 2015 (246012): 1–16.
16 Bharti, C., Nagaich, U., Pal, A.K., and Gulati, N. (2015). Mesosporus silica nanoparticles in target drug delivery system: a review. International Journal of Pharmaceutical Investigation 5 (3): 124–134.
17 Blume, G. and Ceve, G. (1990). Liposomes for the sustained drug release in vivo. Biochimica et Biophysica Acta 1029 (1): 91–97.
18 Bonnard, T., Gauberti, M., de Lizarrondo, S.M. et al. (2019). Recent advances in nanomedicine for ischemic and hemorrhagic stroke. Stroke 50: 1318–1324.
19 Chandra, A., Joshi, K., and Aggarwal, G. (2018). Topical nano drug delivery for treatment of psoriasis: progressive and novel delivery. Asian Journal of Pharmaceutics 12 (3): S835–S848.
20 Chansuvarn, W., Tuntulani, T., and Imyim, A. (2015). Colorimetric detection of mercury(II) based on gold nanoparticles, fluorescent gold nanoclusters and other gold‐based nanomaterials. TrAC Trends in Analytical Chemistry 65: 83–96.
21 Chen, T.J., Cheng, T.H., Chen, C.Y. et al. (2009). Targeted Herceptin dextraniron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. Journal of Biological Inorganic Chemistry 14 (2): 253–260.
22 Chen, Y., Wang, Y., Liu, L. et al. (2015). A gold immunochromatographic assay for the rapid and simultaneous detection of fifteen β‐lactams. Nanoscale 7: 16381–16388.
23 Cho, K., Wang, X.U., Nie, S., and Shin, D.M. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research 14 (5): 1310–1316.
24 Choudhary, S., Gupta, L., Rani, S. et al. (2017). Impact of dendrimers on solubility of hydrophobic drug molecules. Frontiers in Pharmacology 8: 261. https://doi.org/10.3389/fphar.2017.00261.
25 Crucho, C.I.C. and Barros, M.T. (2017). Polymeric nanoparticles: a study on the preparation variables and characterization methods. Materials Science and Engineering C 80: 771–784.
26 Dudefoi, W., Villares, A., Peyron, S. et al. (2018). Nanoscience and nanotechnologies for biobased materials, packaging and food applications: new opportunities and concerns. Innovative Food Science & Emerging Technologies 46: 107–121.
27 Dykman, L. and Khlebtsov, N. (2012). Gold nanoparticles in biomedical applications: recent advances and perspectives. Chemical Society Reviews 41: 2256–2282.
28 El‐Hammadi, M.M. and Arias, J.L. (2019). An update on liposomes in drug delivery: a patent review (2014‐2018). Expert Opinion on Therapeutic Patents 29 (11): 891–907.
29 Gao, X., Cui, Y., Levenson, R.M. et al. (2004). In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology 22 (8): 969–976.
30 Gatoo, M.A., Naseem, S., Arfat, M.Y. et al. (2014). Physicochemical properties of nanomaterials: implication in associated toxic manifestations. BioMed Research International 2014 (498420) https://doi.org/10.1155/2014/498420.
31 Gholami‐Shabani, M., Akbarzadeh, A., Norouzian, D. et al. (2014). Antimicrobial activity and physical characterization of silver nanoparticles green synthesized using nitrate reductase from Fusarium oxysporum. Applied Biochemistry and Biotechnology 172 (8): 4084–4408.
32 Gholami‐Shabani, M., Shams‐Ghahfarokhi, M., Gholami‐Shabani, Z. et al. (2015). Enzymatic synthesis of gold nanoparticles using sulfite reductase purified from Escherichia coli: a green eco‐friendly approach. Process Biochemistry 50 (7): 1076–1085.
33 Gholami‐Shabani,
